review · Cancers

Understanding the Significance of Hypoxia-Inducible Factors (HIFs) in Glioblastoma: A Systematic Review

Emir Begagić
Fatima Juković-Bihorac
Amina Džidić-Krivić
Semir Hadžić
Sabina Šegalo
Emsel Papić
S Duricić
Alma Mekić–Abazović
Samra Kadić Vukas
Hakija Bečulić
Ragib Pugonja
Adem Nuhović
Tarik Kasapović
Dalila Kavgić
Emmanuel Muchai
Mirza Pojskić

202420 citationsOpen accessKenyatta University

Abstract

Overcoming challenges such as treatment resistance and the absence of biomarkers is critical for the effective integration of HIF-related therapies into the treatment of glioblastoma with the aim of optimizing patient outcomes.

Research topics

Cancer, Hypoxia, and Metabolism
Glioma Diagnosis and Treatment
Neuroblastoma Research and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.3390/cancers16112089

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.